Tamiola had an opportunity early in his career to collaborate with researchers studying proteins implicated in progressive neurodegenerative disorders, like human alpha-synuclein and tau.

Orchard Therapeutics’ Lenmeldy™ is a first of its kind treatment for an ultra-rare pediatric hereditary disorder. F-Prime is dedicated to advancing pioneering science and technologies ...

“It was really striking to me how little research and development was going on despite how serious these diseases are. Many of them are deadly, ...